Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02923739 |
Title | Induction Discontinuation Trial of Emactuzumab Following Paclitaxel and Bevacizumab in Patients With Platinum-Resistant, Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer - REDIRECT |
Recruitment | Terminated |
Gender | female |
Phase | Phase II |
Variant Requirements | No |
Sponsors | M.D. Anderson Cancer Center |
Indications | |
Therapies | |
Age Groups: | senior | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
MD Anderson Cancer Center at Cooper-Voorhees | Voorhees | New Jersey | 08043 | United States | Details | |
UT Southwestern/Simmons Cancer Center-Dallas | Dallas | Texas | 75390 | United States | Details | |
M D Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
The Woman's Hospital of Texas | Houston | Texas | 77054 | United States | Details | |
MD Anderson Regional Care Center-Katy | Houston | Texas | 77094 | United States | Details | |
MD Anderson Regional Care Center-Bay Area | Nassau Bay | Texas | 77058 | United States | Details | |
MD Anderson Regional Care Center-Sugar Land | Sugar Land | Texas | 77478 | United States | Details | |
MD Anderson Regional Care Center-The Woodlands | The Woodlands | Texas | 77384 | United States | Details |